Joanna Kosałka-Węgiel Mamert Milewski Andżelika Siwiec Magdalena Strach Bogdan Ochrem Mariusz Korkosz
10.5114/ceji.2021.108259
Cent Eur J Immunol
2021;46(3):395-397.
hes il-5 il-5 receptor benralizumab hypereosinophilic syndrome monoclonal antibody
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/34764813/
Case Reports
PMC8574116
34764813
Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α - benralizumab
2021